Carotid endarterectomy for carotid stenosis: audit at a tertiary referral centre by Lau, H & Cheng, SWK
Title Carotid endarterectomy for carotid stenosis: audit at a tertiaryreferral centre
Author(s) Lau, H; Cheng, SWK
Citation Hong Kong Medical Journal, 1999, v. 5 n. 4, p. 387-390
Issued Date 1999
URL http://hdl.handle.net/10722/45403
Rights Creative Commons: Attribution 3.0 Hong Kong License
HKMJ Vol 5 No 4 December 1999      387
Carotid endarterectomy for carotid stenosis
Introduction
Stroke is a serious health problem in most developed
countries. It is a major cause of disability and death
in the elderly. The treatment of patients with stroke
has become a substantial financial burden to society.
Performing carotid endarterectomy is one of the most
effective strategies of preventing ischaemic cerebro-
vascular disease.1
Prospective randomised controlled trials performed
in North America and Europe have demonstrated the
benefits of carotid endarterectomy in symptomatic
patients with severe carotid stenosis.2,3 However, the
major risks of this procedure are stroke and stroke-
related death. The real benefit of this procedure there-
fore relies on a balance between the outcome and
the risks of the operation. Patients will benefit from
this procedure as long as the perioperative morbidity
and mortality rates are kept within the defined limits.
To confer the benefit of carotid endarterectomy, it is
imperative for the operating surgeon to demonstrate
an acceptable surgical complication rate. The pur-
pose of this study was to audit the results of carotid
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Prospective randomised controlled trials performed in North America and Europe have demonstrated
that the risk of future stroke or death is substantially reduced by performing carotid endarterectomy in
symptomatic patients who have severe carotid stenosis. An audit was conducted to analyse the results of
carotid endarterectomy performed during a 3-year period, at a tertiary referral vascular centre in Hong
Kong. A total of 35 patients who had significant carotid stenosis underwent 36 carotid endarterectomies
from October 1994 to September 1997. All patients recovered uneventfully without neurological compli-
cations or mortality. The audit showed that the current results of carotid endarterectomy at this institu-
tion fulfilled the criteria advised by the Stroke Council of the American Heart Association in 1995.
Therefore, carotid endarterectomy is a validated therapeutic option for carotid stenosis in Hong Kong.
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endarterectomy at the Queen Mary Hospital during a
3-year period.
Methods
From October 1994 to September 1997, a total of 35
patients with haemodynamically significant carotid
stenosis (≥70%) underwent 36 carotid endarterecto-
mies at the Division of Vascular Surgery at the Queen
Mary Hospital. One patient underwent staged bilateral
carotid endarterectomy. A retrospective analysis of the
patient records was performed. Demographic data,
including risk factors and associated medical diseases,
were documented. The indications for surgery, and the
early and long-term outcomes of surgical intervention
were reviewed.
Preoperative evaluation
Non-invasive colour doppler carotid duplex scanning
was performed to confirm the diagnosis that was made
at the time of presentation (Fig 1). In patients who
presented with focal symptoms, computed tomogra-
phy of the brain was used to rule out intracranial
pathology. Arch aortography and bilateral carotid and
vertebral arteriography were performed to assess the
degree of stenosis and delineate the extent of disease
(Fig 2). A preoperative cardiovascular evaluation
was performed for all patients. The identification and
modification of risk factors, such as the cessation of
smoking and the optimal control of diabetes mellitus,
cardiac disease, hypertension, and hyperlipidaemia,
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were achieved in all patients prior to the operation.
Aspirin 150 mg/d was prescribed for all patients.
Operative techniques
While the patient was receiving general anaesthesia,
an oblique cervical incision was made anterior to the
sternocleidomastoid muscle. After the carotid sheath
and carotid bifurcation were exposed, the vagus and
hypoglossal nerves were identified and protected.
Systemic heparin was then given and arterial clamps
were applied. An arteriotomy was made at the site of
the occlusion and a Javid inlay shunt was inserted
whenever it was feasible to do so (Fig 3). The athero-
sclerotic plaque was then dissected from the internal
carotid artery. The endarterectomy was completed by
extracting the plaque from the external carotid artery
(Fig 4). The arteriotomy was closed using a continu-
ous suture of 6-O monofilament polypropylene. Intra-
operative duplex scanning was performed prior to
wound closure to detect any intimal flaps or flow
disturbances of the carotid arteries. The neurological
status of the patient was closely monitored in the
postoperative period.
Follow-up
The duration of follow-up was calculated from the
date of the operation to the date of the latest follow-up
visit. After the first 1-month visit, all patients received
regular follow-up at the Vascular Clinic of the Depart-
ment of Surgery at the Queen Mary Hospital every
3 months. Aspirin 150 mg/d was routinely prescribed.
Any recurrence of neurological symptoms was docu-
mented. Follow-up carotid duplex scanning was per-
formed every 6 months to detect any recurrent stenoses.
Results
Demographic data
The mean age of the study population was 70 years (range,
58-86 years) and the male to female ratio was 6:1. The
patients had a history of one or more of the following
medical diseases: hypertension (n=24), ischaemic heart
disease (n=17), diabetes mellitus (n=12), and hyper-
lipidaemia (n=7). Of the 35 patients, 29 (83%) were
currently or formerly chronic smokers, 17 (49%) had
a history of stroke, and 19 (54%) had experienced
Fig 1. Colour doppler carotid duplex scan showing a high-veloc-
ity stenosis (arrow)
Fig 2. Carotid arteriogram showing a significant
stenotic lesion of the internal carotid artery
Fig 3. Intra-operative photograph showing the carotid arteri-
otomy with a Javid inlay shunt in situ after
endarterectomy
Fig 4. Carotid atherosclerotic plaque removed from the origin of
the internal carotid artery
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transient ischaemic attacks. The mean degree of carotid
stenosis was 85% (standard deviation [SD], 12%).
Operative results
The indications for surgical intervention were transient
ischaemic attacks (n=12), minor stroke (n=17), and
asymptomatic patients with high-grade stenosis (n=7).
The mean duration of the operation was 2 hours 10
minutes (SD, 16 minutes). The mean blood loss was
40 mL (SD, 50 mL). An intra-operative shunt was used
for 28 (80%) patients. After the operation, two patients
had wound haematoma, and cardiac arrhythmia
developed in one patient on the first postoperative
day; the morbidity rate was 8%. All patients recovered
uneventfully and without any neurological deficit.
There was no operative or hospital mortality. The mean
duration of postoperative hospital stay was 6 days
(range, 3-13 days).
Results at follow-up
The median duration of follow-up was 18 months
(range, 6-40 months). One patient defaulted follow-up at
6 months. Two (6%) patients had recurrent stenosis,
as detected by surveillance carotid duplex scanning.
Of these two patients, one remained asymptomatic
and declined further operation. The other patient
experienced transient ischaemic attacks and underwent
carotid endarterectomy with vein patch angioplasty
in October 1997. He recovered uneventfully from
the operation. All patients remained alive and well,
and no further transient ischaemic attacks or stroke
were reported at the last follow-up in February 1998.
Discussion
Carotid endarterectomy has been shown to be an
effective therapy for symptomatic high-grade (≥70%)
carotid artery stenosis in a number of randomised
controlled trials performed in North America and
Europe. 2-5 The North American Symptomatic Carotid
Endarterectomy Trial Collaborators found that the
cumulative risk of the recurrence of stroke at 2 years
was 26% in 331 medically treated patients and
9% in 328 surgically treated patients2—an absolute
risk reduction of 17%. The European Carotid Surgery
Trialists’ Collaborative Group3 reported similar results.
In 778 patients with severe carotid stenosis (70%-99%),
a six-fold reduction of the rate of stroke recurrence at
3 years was observed in the surgically treated patients
compared with control patients taking aspirin.3
Many patients who have generalised atherosclerotic
arterial occlusive disease will die of cardiac attacks
instead of stroke. Enhancing the quality of life rather
than just prolonging survival is a major consideration
in the long-term treatment of patients who are at risk
of stroke. Carotid endarterectomy is a prophylactic
operation that is designed to reduce the risk of disabling
or fatal stroke occurring in the future. The removal of the
stenotic lesion prevents hypoperfusion and embolism.
Patients who undergo carotid endarterectomy
usually have minor or no symptoms. The justification
of performing this procedure, however, relies on a
balance between the benefits and the risks of the
operation. It is imperative to keep the operative risk—
particularly that of perioperative stroke and death—to
a minimum.6 Operative risk depends not only on the
surgeon’s skill and the quality of perioperative care,
but also the patient’s general health status and the
indications for surgery.7 The risk of perioperative
stroke is lowest in asymptomatic patients and highest
in patients who have a history of stroke.8
There has been controversy about who should
perform a carotid endarterectomy. The identification
of problems by performing regular audits will help
improve the results of surgery and the quality of care
within an institution. The audit should be objective,
unbiased, and accurate—especially with regard to
surgical morbidity and mortality—and be made pub-
licly available. In North America, only those surgeons
and institutions that were able to provide proof of an
acceptable standard of surgical competence were
allowed to participate in the carotid endarterectomy
trial.2 In 1995, the Stroke Council of the American
Heart Association reviewed available reports and
recommended the upper acceptable limits of surgeons’
combined perioperative stroke and mortality rates
for various indications for carotid endarterectomy.7
The limits were 3% for asymptomatic patients, 5%
for patients who had experienced transient ischaemic
attack, 7% for patients with previous stroke, and 10%
for patients undergoing surgery for recurrent stenosis.
The benefit conferred by surgery will diminish once
the perioperative complication rate exceeds the
acceptable limits.
During the 3 years of this study, there was no post-
operative neurological complication or mortality after
carotid endarterectomy at the Queen Mary Hospital.
During the postoperative period, only two patients
had mild wound bruising and one patient experienced
cardiac arrhythmia on the first postoperative day.
During follow-up, two patients were shown to have
recurrent stenosis; although these two patients
remained well, one of them had a restenosis within
1 year. The current combined perioperative stroke
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and mortality rate of this audit falls within the accept-
able range proposed by the Stroke Council of the
American Heart Association.7
The relatively small proportion (33%) of patients
who underwent surgery for transient ischaemic attacks
in this study indicates that carotid stenosis may have
been underdiagnosed in Hong Kong. The past lack of
awareness of this condition among physicians, the
formidable complication (ie stroke), and the previous
paucity of surgical expertise are possible reasons for
the underdiagnosis. Owing to the increasing influence
of western lifestyles, the incidence of atherosclerotic
arterial occlusive disease, including carotid stenosis,
has been increasing in Hong Kong.9 The timely identifi-
cation of at-risk patients plays an important role in
primary health care. Patients with carotid stenosis should
be referred for further assessment and treatment.10,11
Carotid angioplasty and stenting are regarded as
investigative procedures and are preferably limited
to clinical trials only.12,13 Most reports have shown
that carotid angioplasty and stenting have a higher
complication rate than carotid endarterectomy.14,15 The
efficacy of the former procedure has not been tested
by a randomised trial, but in difficult cases and medi-
cally unfit patients, endovascular intervention is a
feasible option.
In conclusion, carotid endarterectomy is a viable
treatment for carotid stenosis in Hong Kong. Patients
with a significant carotid lesion (≥70%) are potential
candidates for carotid endarterectomy.
Acknowledgements
We wish to thank Mrs WLH Wong, who performed
the carotid duplex scanning, and staff at the Francis
YH Tien Vascular Disease Centre of the Queen Mary
Hospital for their invaluable assistance with the data
collection.
References
1. Eikelboom BC. Carotid endarterectomy: confidence restored.
Br J Surg 1993;80:821-2.
2. North American Symptomatic Carotid Endarterectomy Trial
Collaborators. Beneficial effect of carotid endarterectomy in
symptomatic patients with high-grade carotid stenosis. N Engl
J Med 1991;325:445-53.
3. European Carotid Surgery Trialists’ Collaborative Group.
MRC European Carotid Surgery Trial: interim results for
symptomatic patients with severe (70-99%) or with mild
(0-29%) carotid stenosis. Lancet 1991;337:1235-43.
4. Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterec-
tomy and prevention of cerebral ischemia in symptomatic
carotid stenosis. Veterans Affairs Cooperative Studies Program
309 Trialist Group. JAMA 1991;266:3289-94.
5. Executive Committee for the Asymptomatic Carotid Athero-
sclerosis Study. Endarterectomy for asymptomatic carotid
artery stenosis. JAMA 1995;273:1421-8.
6. Moore WS, Mohr JP, Najafi H, Robertson JT, Stoney RJ, Toole
JF. Carotid endarterectomy: practice guidelines. Report of
the Ad Hoc Committee to the Joint Council of the Society
for Vascular Surgery and the North American Chapter of the
International Society for Cardiovascular Surgery. J Vasc Surg
1992;15:469-79.
7. Moore WS, Barnett HJ, Beebe HG, et al. Guidelines for
carotid endarterectomy. A multidisciplinary consensus state-
ment from the Ad Hoc Committee, American Heart Associa-
tion. Circulation 1995;91:566-79.
8. The European Carotid Surgery Trialists Collaborative Group.
Risk of stroke in the distribution of an asymptomatic carotid
artery. Lancet 1995;345:209-12.
9. Cheng SW, Wong J. Development of vascular surgery in Hong
Kong. Asian J Surg 1996;19:6-10.
10. Humphrey PR. Management of transient ischaemic attacks
and stroke. Postgrad Med J 1995;71:577-84.
11. Taylor DC. 2. Current noninvasive diagnosis of carotid artery
stenosis: indications and limitations. Can J Surg 1994;37:
114-23.
12. Grotta J. Elective stenting of extracranial carotid arteries
[editorial]. Circulation 1997;95:303-5.
13. Lau JW, Yeung CK. Carotid stenting and angioplasty [letter].
HKMJ 1999;5:208-9.
14. Yadav JS, Roubin GS, Iyer S, et al. Elective stenting of the
extracranial carotid arteries. Circulation 1997;95:376-81.
15. Society for Vascular Surgery. International Society for Cardio-
vascular Surgery, North American Chapter. Statement regard-
ing carotid angioplasty and stenting. J Vasc Surg 1996; 24:900.
